Metropolitan Life Insurance Company (MetLife)’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-2,405
| Closed | -$237K | – | 2711 |
|
|
2021
Q1 | $237K | Sell |
2,405
-177
| -7% | -$17.5K | ﹤0.01% | 1898 |
|
|
2020
Q4 | $280K | Hold |
2,582
| – | – | ﹤0.01% | 1717 |
|
|
2020
Q3 | $266K | Buy |
2,582
+330
| +15% | +$34K | ﹤0.01% | 1602 |
|
|
2020
Q2 | $470K | Buy |
2,252
+263
| +13% | +$54.9K | 0.01% | 1250 |
|
|
2020
Q1 | $194K | Buy |
1,989
+515
| +35% | +$50.3K | ﹤0.01% | 1606 |
|
|
2019
Q4 | $170K | Sell |
1,474
-591
| -29% | -$68.1K | ﹤0.01% | 2035 |
|
|
2019
Q3 | $113K | Hold |
2,065
| – | – | ﹤0.01% | 2236 |
|
|
2019
Q2 | $246K | Hold |
2,065
| – | – | ﹤0.01% | 1761 |
|
|
2019
Q1 | $108K | Buy |
+2,065
| New | +$108K | ﹤0.01% | 2285 |
|
|
2018
Q4 | – | Sell |
-2,002
| Closed | -$121K | – | 2548 |
|
|
2018
Q3 | $121K | Hold |
2,002
| – | – | ﹤0.01% | 2341 |
|
|
2018
Q2 | $106K | Buy |
+2,002
| New | +$106K | ﹤0.01% | 2288 |
|
|
2015
Q4 | – | Sell |
-1,478
| Closed | -$122K | – | 2580 |
|
|
2015
Q3 | $122K | Hold |
1,478
| – | – | ﹤0.01% | 2547 |
|
|
2015
Q2 | $240K | Buy |
+1,478
| New | +$240K | ﹤0.01% | 2275 |
|
|
2015
Q1 | – | Sell |
-569
| Closed | -$307K | – | 2220 |
|
|
2014
Q4 | $307K | Sell |
569
-297
| -34% | -$160K | ﹤0.01% | 2111 |
|
|
2014
Q3 | $296K | Buy |
+866
| New | +$296K | ﹤0.01% | 2089 |
|